Check out the Top Ten most popular articles on Pharmafile.com this week!
According to new data from intelligence provider GBI Research, the flu vaccines market in the Asia-Pacific (APAC) region is set to grow from $1.24...
A new study has estimated that one in four men could avoid unnecessary invasive biopsies to detect prostate cancer by utilising advanced MRI...
Johnson & Johnson’s Imbruvica (ibrutinib) has scored its fifth indication approval in the US for the treatment of Marginal Zone Lymphoma (MZL...
Happy New Year from us here at Pharmafocus! As we leave 2016 behind, take a look at ten of its biggest stories, according to our readers.